Related Experiment Video

Updated: May 19, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Decoding the BRCA2 reversion principles underlying PARP inhibitor resistance

Anna Gabrielle Horacek1, Frances Li Kueper1, Robert Lu1

  • 1Department of Molecular and Cell Biology, University of California, Berkeley; Berkeley, CA 94720, USA.

Biorxiv : the Preprint Server for Biology
|May 18, 2026
PubMed

Insights

Reversion mutations can restore BRCA2 function, leading to resistance against poly(ADP-ribose) polymerase inhibitors (PARPi) in BRCA2-mutant cancers. Understanding these reversion mechanisms helps predict PARPi resistance and guide cancer treatment strategies.

Area of Science:

  • Genomics and Cancer Biology
  • Molecular Mechanisms of Drug Resistance

Background:

  • Poly(ADP-ribose) polymerase inhibitors (PARPi) are effective against BRCA2-mutant cancers.
  • Acquired resistance to PARPi often arises from reversion mutations that restore BRCA2 function.

Purpose of the Study:

  • To elucidate the principles governing BRCA2 reversion mutations.
  • To identify mechanisms conferring poly(ADP-ribose) polymerase inhibitor resistance.
  • To develop a predictive framework for BRCA2 reversion events.

Main Methods:

  • Utilized an isogenic cell system for controlled experiments.
  • Employed CRISPR gene editing to precisely engineer BRCA2 reversion mutations.
  • Analyzed DNA-level sequence context and transcript-level alternative splicing events.

Main Results:

  • Sequence context dictates the types of BRCA2 reversions observed.
  • Domain architecture determines whether a reversion confers poly(ADP-ribose) polymerase inhibitor resistance.
  • Identified two major reversion routes: DNA reading-frame restoration and transcript-level splicing rescue.
  • Characterized exon 11 reversion mechanisms, including deletions and splice isoforms affecting BRC repeats.

Conclusions:

  • Defined a predictive code for BRCA2 reversion and poly(ADP-ribose) polymerase inhibitor resistance.
  • Findings inform strategies for predicting and overcoming PARPi resistance in BRCA2-mutant cancers.
Keywords:
BRCAPARP inhibitor resistancebreastgenetic reversionovarianprostate cancer

More Related Videos

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

Related Concept Videos

Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
Base-pairing and DNA Repair02:27

Base-pairing and DNA Repair

Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...